W. Mark Saltzman

Yale University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

96h-index30.4kcitations544works5.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA Interference and Gene Delivery(132), Nanoparticle-Based Drug Delivery(92), Advanced biosensing and bioanalysis techniques(59), 3D Printing in Biomedical Research(45), Advanced Drug Delivery Systems(44)

Publications539 total

Endothelial cell MHC molecules are necessary and sufficient to reject 3D-printed human skin grafts in an advanced human immune system mouse
2025Open Access
Mosaic pattern: lung functional heterogeneity at the alveolus level
2025Open Access
Abstract A100: Systemic targeting of therapeutic RNA into pancreatic tumors via an RNA-binding and cell-penetrating antibody
Cancer Research·2025
Systemic administration of an RNA binding and cell-penetrating antibody targets therapeutic RNA to multiple mouse models of cancer
Science Translational Medicine·2025· 4 cited
Systemic in utero gene editing as a treatment for cystic fibrosis
Proceedings of the National Academy of Sciences·2025· 3 citedOpen Access
Fertile Ground for Mathematical Modeling: Therapeutic and Diagnostic Nanoparticle Transport in the Glomerulus
Regenerative Engineering and Translational Medicine·2025
Cellular determinants influence the red blood cell adsorption efficiency of poly(amine- <i>co</i> -ester) nanoparticles
Science Advances·2025· 4 citedOpen Access
Targeting Polymeric Nanoparticles to Specific Cell Populations in the Liver
Biochemistry·2025· 3 cited
Investigation of the protein corona and biodistribution profile of polymeric nanoparticles for intra-amniotic delivery
Biomaterials·2025· 4 cited
Biodistribution of Polymeric Nanoparticles following in utero Delivery to a Nonhuman Primate
Biomedicine Hub·2024· 1 citedOpen Access
IL-1β Induces Human Endothelial Surface Expression of IL-15 by Relieving let-7c-3p Suppression of Protein Translation
The Journal of Immunology·2024· 3 citedOpen Access
Abstract PR-01: Systemic targeting of therapeutic RNA to pancreatic ductal adenocarcinoma via a novel, cell-penetrating, and nucleic acid-binding monoclonal antibody
Cancer Research·2024
Systemic in utero gene editing as a treatment for cystic fibrosis
2024· 3 citedOpen Access
295 Polymeric nanoparticles for in utero gene delivery in non-human primates
Journal of Cystic Fibrosis·2024
285 Development of an electrochemiluminescence CFTR immunoassay
Journal of Cystic Fibrosis·2024
264 Poly(amine-co-ester) nanoparticle delivery of CFTR mRNA shows restoration of CFTR activity in cystic fibrosis airway models
Journal of Cystic Fibrosis·2024
Enhanced Intratumoral Delivery of Immunomodulator Monophosphoryl Lipid A through Hyperbranched Polyglycerol–Coated Biodegradable Nanoparticles
Journal of Investigative Dermatology·2024· 4 cited
Next generation triplex-forming PNAs for site-specific genome editing of the F508del CFTR mutation
Journal of Cystic Fibrosis·2024· 1 citedOpen Access
Figure S2 from Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors
2024Open Access
Figure S2 from Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors
2024Open Access
page 1 of 27Next →

Frequent Co-authors

Christopher J. Cheng(6), Dan Luo(4), Toral Patel(4), Jiangbing Zhou(4), Carmen J. Booth(4), Tarek M. Fahmy(4), Raman Bahal(3), Peter M. Glazer(3), Frank J. Slack(3), Jordan S. Pober(3), Joseph M. Piepmeier(3), Lawrence K. Fung(3), Jian Tan(3), Imran Babar(2), Demetrios T. Braddock(2), Jason D. Roh(2), Matthew Brennan(2), Steven M. Jay(2), Tai Yi(2), Tamar L. Mirensky(2)